Overview

Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the imaging characteristics of flortaucipir in subjects with a previous flortaucipir scan in order to assess the rate of change of tau deposition over time.
Phase:
Phase 2
Details
Lead Sponsor:
Avid Radiopharmaceuticals